Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular EventsMarc S. Sabatine, Evan A. Stein, Jason C. Legg et al.|New England Journal of Medicine|2015Cited by 1.5k
Comparison of the Framingham and Reynolds Risk Scores for Global Cardiovascular Risk Prediction in the Multiethnic Women's Health InitiativeNancy R. Cook, Paul M. Ridker, Nina P. Paynter et al.|Circulation|2012Cited by 263
Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in LifeJennifer G. Robinson, Allan D. Sniderman, Kevin Jon Williams et al.|Journal of the American Heart Association|2018Cited by 105
Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women’s Health InitiativeSamia Mora, JoAnn E. Manson, Nanette K. Wenger et al.|JAMA Internal Medicine|2018Cited by 83